EssilorLuxottica SA
EL
ISIN FR0000121667 / Valor 497537
EssilorLuxottica SA
UMushroom community rating:
About company
EssilorLuxottica SA is a global leader in the design, manufacture, and distribution of ophthalmic lenses, optical equipment, and prescription glasses and sunglasses. The company represents a merger of two industry giants, Essilor and Luxottica, combining their strengths in lens technology and eyewear brands. EssilorLuxottica's portfolio includes some of the most iconic names in the eyewear industry, such as Ray-Ban, Persol, and Oakley, alongside optical retailers like Salmoiraghi & Viganò and GrandVision. The company's history is rich, with roots tracing back to the 19th century, showcasing a long-standing tradition in the eyecare and eyewear sector. Through its comprehensive approach that covers every aspect of the eyewear experience—from innovation and design to production and distribution—EssilorLuxottica has established itself as a key player in the global market, dedicated to advancing the eyecare and eyewear industry for consumers around the world.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (22.10.2025):
EssilorLuxottica SA reported its best quarterly performance ever in the third quarter of 2025, achieving a consolidated revenue of €6,867 million. This represents an 11.7% year-on-year increase at constant exchange rates, driven by significant growth in wearables, vision care, and sunglasses, as well as strong performances in North America and EMEA regions.
Revenue Growth
The Group's revenue surged by 11.7% in Q3 2025 at constant exchange rates, marking the highest quarterly revenue in the company's history. Over the nine-month period, revenue increased by 8.8%, reflecting sustained growth across various segments.
Product Innovation and Wearables
Wearables contributed significantly to the revenue boost, supported by an expanding portfolio and a robust pipeline of product innovations. The introduction of next-generation Ray-Ban Meta and Oakley Meta glasses exemplifies EssilorLuxottica's commitment to pioneering advancements in wearable technology.
Regional Performance
Both North America and EMEA regions experienced double-digit growth in both PS (Professional Services) and DTC (Direct-to-Consumer) channels. These regional successes were pivotal in driving the overall revenue increase for the Group.
Strategic Acquisitions and Innovations
The acquisition of RetinAI and the closure of Optegra eye clinics, set to be consolidated in October, strengthen EssilorLuxottica's vision-health ecosystem. Additionally, the Stellest lenses received full FDA approval, enhancing the company's leadership in myopia management and expanding its market presence in the U.S.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
162497 M
Market cap (USD)
678,984
Daily traded volume (Shares)
235.2 / 231.9
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Hugo Raffard
Matheo Mesny
EQUITIES OF THE SAME SECTOR
